Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-26T00:39:02.281Z Has data issue: false hasContentIssue false
  • English
  • Français

The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis

Published online by Cambridge University Press:  23 January 2020

Z. Wang ,
I.C.K. Wong ,
K.K.C. Man ,
B.H. Alfageh ,
P. Mongkhon  and
R. Brauer
Z. Wang*
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK
I.C.K. Wong
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong, China
K.K.C. Man
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong, China
B.H. Alfageh
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia
P. Mongkhon
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand
R. Brauer
Affiliation:
Research Department of Practice and Policy, UCL School of Pharmacy, London, UK
*
Author for correspondence: Z. Wang, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Previous studies have found contradicting results with regard to the use of antipsychotics during pregnancy and the risk of gestational diabetes mellitus (GDM). We aimed to evaluate the association between antipsychotic use in pregnancy and GDM.

Methods

A systematic literature search was conducted in PubMed, EMBASE, PsycINFO and Cochrane Library databases up to March 2019, for data from observational studies assessing the association between gestational antipsychotic use and GDM. Non-English studies, animal studies, case reports, conference abstracts, book chapters, reviews and summaries were excluded. The primary outcome was GDM. Estimates were pooled using a random effect model, with the I2 statistic used to estimate heterogeneity of results. Our study protocol was registered with PROSPERO number: CRD42018095014.

Results

In total 10 cohort studies met the inclusion criteria in our systematic review with 6642 exposed and 1 860 290 unexposed pregnancies. Six studies were included in the meta-analysis with a pooled adjusted relative risk of 1.24 overall [95% confidence interval (CI) 1.09–1.42]. The I2 result suggested low heterogeneity between studies (I2 = 6.7%, p = 0.373).

Conclusion

We found that the use of antipsychotic medications during pregnancy is associated with an increased risk of GDM in mothers. However, the evidence is still insufficient, especially for specific drug classes. We recommend more studies to investigate this association for specific drug classes, dosages and comorbidities to help clinicians to manage the risk of GDM if initiation or continuation of antipsychotic prescriptions during pregnancy is needed.

Keywords

Antipsychoticsgestational diabetespregnancy
Type
Original Articles
Information
Psychological Medicine , Volume 51 , Issue 6 , April 2021 , pp. 1028 - 1037
Check for updates
Copyright
Copyright © Cambridge University Press 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andersson, L., Sundström-Poromaa, I., Bixo, M., Wulff, M., Bondestam, K., & Åström, M. (2003). Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study. American Journal of Obstetrics & Gynecology, 189(1), 148–154.CrossRefGoogle ScholarPubMed
American Diabetes Association. (2004). Gestational diabetes mellitus. Diabetes care, 27, S88.CrossRefGoogle Scholar
American Diabetes Association. (2017). Management of diabetes in pregnancy. Retrieved from http://care.diabetesjournals.org/content/40/Supplement_1/S114.Google Scholar
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014). Almost all antipsychotics result in weight gain: A meta-analysis. PLoS One, 9(4), e94112.CrossRefGoogle ScholarPubMed
Barbui, C., Conti, V., Purgato, M., Cipriani, A., Fortino, I., Rivolta, A., & Lora, A. (2013). Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: Epidemiological survey. Epidemiology and Psychiatric Sciences, 22(4), 355–361.CrossRefGoogle ScholarPubMed
Bellet, F., Beyens, M. N., Bernard, N., Beghin, D., Elefant, E., & Vial, T. (2015). Exposure to aripiprazole during embryogenesis: A prospective multicenter cohort study. Pharmacoepidemiology and Drug Safety, 24(4), 368–380. doi:10.1002/pds.3749.CrossRefGoogle ScholarPubMed
Bobo, W. V., Cooper, W. O., Stein, C. M., Olfson, M., Graham, D., Daugherty, J., … Ray, W. A. (2013). Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry, 70(10), 1067–1075.CrossRefGoogle ScholarPubMed
Boden, R., Lundgren, M., Brandt, L., Reutfors, J., & Kieler, H. (2012). Antipsychotics during pregnancy: Relation to fetal and maternal metabolic effects. Archives of General Psychiatry, 69(7), 715–721.CrossRefGoogle ScholarPubMed
Brand, J. S., West, J., Tuffnell, D., Bird, P. K., Wright, J., Tilling, K., & Lawlor, D. A. (2018). Gestational diabetes and ultrasound-assessed fetal growth in South Asian and White European women: Findings from a prospective pregnancy cohort. BMC Medicine 16(1), 203.CrossRefGoogle ScholarPubMed
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., … Aquino, P. R. (2009). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin, 36(1), 71–93.CrossRefGoogle ScholarPubMed
Byerly, M. J., Nakonezny, P. A., & Lescouflair, E. (2007). Antipsychotic medication adherence in schizophrenia. Psychiatric Clinics of North America, 30(3), 437–452.CrossRefGoogle Scholar
Cnattingius, S., & Lambe, M. (2002). Trends in smoking and overweight during pregnancy: Prevalence, risks of pregnancy complications, and adverse pregnancy outcomes. Seminars in Perinatology, 26(4), 286–295.CrossRefGoogle ScholarPubMed
Cohen, L. S., & Rosenbaum, J. F. (1998). Psychotropic drug use during pregnancy: Weighing the risks. The Journal of Clinical Psychiatry, 59, 18–28.Google ScholarPubMed
De Hert, M., Dobbelaere, M., Sheridan, E., Cohen, D., & Correll, C. (2011). Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry, 26(3), 144–158.CrossRefGoogle Scholar
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188.CrossRefGoogle ScholarPubMed
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014). Peer reviewed: Prevalence estimates of gestational diabetes mellitus in the United States, pregnancy risk assessment monitoring system (prams), 2007–2010. Preventing Chronic Disease, 11, E104–E104.CrossRefGoogle Scholar
Frayne, J., Nguyen, T., Bennett, K., Allen, S., Hauck, Y., & Liira, H. (2017). The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness. Australian and New Zealand Journal of Obstetrics and Gynaecology, 57(5), 526–532.CrossRefGoogle ScholarPubMed
Galbally, M., Snellen, M., & Power, J. (2014). Antipsychotic drugs in pregnancy: A review of their maternal and fetal effects. Therapeutic Advances in Drug Safety, 5(2), 100–109.CrossRefGoogle ScholarPubMed
Gentile, S. (2008). Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophrenia Bulletin, 36(3), 518–544.CrossRefGoogle ScholarPubMed
Guariguata, L., Linnenkamp, U., Beagley, J., Whiting, D. R., & Cho, N. H. (2014). Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Research and Clinical Practice, 103(2), 176–185. doi:10.1016/j.diabres.2013.11.003.CrossRefGoogle ScholarPubMed
Higgins, J. P., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions (Vol. 4). Hoboken, NJ: John Wiley & Sons.Google Scholar
Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ: British Medical Journal, 327(7414), 557.CrossRefGoogle ScholarPubMed
Howard, L. M. (2005). Fertility and pregnancy in women with psychotic disorders. European Journal of Obstetrics and Gynecology and Reproductive Biology, 119(1), 3–10.CrossRefGoogle ScholarPubMed
Jones, I., Chandra, P. S., Dazzan, P., & Howard, L. M. (2014). Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. The Lancet, 384(9956), 1789–1799.CrossRefGoogle ScholarPubMed
Kane, J. M., Kishimoto, T., & Correll, C. U. (2013). Non-adherence to medication in patients with psychotic disorders: Epidemiology, contributing factors and management strategies. World Psychiatry, 12(3), 216–226.CrossRefGoogle ScholarPubMed
Kulkarni, J., Storch, A., Baraniuk, A., Gilbert, H., Gavrilidis, E., & Worsley, R. (2015). Antipsychotic use in pregnancy. Expert Opinion on Pharmacotherapy, 16(9), 1335–1345.CrossRefGoogle ScholarPubMed
Lao, K. S., Tam, A. W., Wong, I. C., Besag, F., Man, K. K., Chui, C. S., & Chan, E. W. (2017). Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups. Pharmacoepidemiology and Drug Safety, 26(11), 1387–1394.CrossRefGoogle Scholar
Luke, B., & Brown, M. B. (2007). Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age. Human Reproduction, 22(5), 1264–1272.CrossRefGoogle ScholarPubMed
Margulis, A. V., Kang, E. M., & Hammad, T. A. (2014). Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort. Maternal and Child Health Journal, 18(7), 1742–1752.CrossRefGoogle Scholar
McKenna, K., Koren, G., Tetelbaum, M., Wilton, L., Shakir, S., Diav-Citrin, O., … Einarson, A. (2005). Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. Journal of Clinical Psychiatry, 66(4), 444–449.CrossRefGoogle ScholarPubMed
Meltzer, H. Y. (2013). Update on typical and atypical antipsychotic drugs. Annual Review of Medicine, 64, 393–406.CrossRefGoogle ScholarPubMed
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández-Díaz, S. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. American Journal of Obstetrics & Gynecology, 205(1), 51. e51–51. e58.CrossRefGoogle ScholarPubMed
NHS. (2018). Gestational diabetes overview. Retrieved from https://www.nhs.uk/conditions/gestational-diabetes/.Google Scholar
NICE. (2014). Antenatal and postnatal mental health: clinical management and service guidance. Retrieved from https://www.nice.org.uk/guidance/cg192.Google Scholar
NICE. (2015). Diabetes in pregnancy: management from preconception to the postnatal period. Retrieved from https://www.nice.org.uk/guidance/ng3.Google Scholar
O'Hara, M. W., Schlechte, J. A., Lewis, D. A., & Varner, M. W. (1991). Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal variables. Journal of Abnormal Psychology, 100(1), 63.CrossRefGoogle ScholarPubMed
Panchaud, A., Hernandez-Diaz, S., Freeman, M. P., Viguera, A. C., MacDonald, S. C., Sosinsky, A. Z., & Cohen, L. S. (2017). Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. Journal of Psychiatric Research, 95, 84–90. doi:10.1016/j.jpsychires.2017.07.025.CrossRefGoogle ScholarPubMed
Park, Y., Hernandez-Diaz, S., Bateman, B. T., Cohen, J. M., Desai, R. J., Patorno, E., … Huybrechts, K. F. (2018). Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. American Journal of Psychiatry, 175(6), 564–574.CrossRefGoogle ScholarPubMed
Parker, B., McFarlane, J., & Soeken, K. (1994). Abuse during pregnancy: Effects on maternal complications and birth weight in adult and teenage women. Obstetrics and Gynecology, 84(3), 323–328.Google ScholarPubMed
Petersen, I., McCrea, R. L., Sammon, C. J., Osborn, D. P. J., Evans, S. J., Cowen, P. J., … Nazareth, I. (2016). Risks and benefits of psychotropic medication in pregnancy: Cohort studies based on UK electronic primary care health records. Health Technology Assessment, 20(23), 1–208.CrossRefGoogle ScholarPubMed
Regenold, W. T., Thapar, R. K., Marano, C., Gavirneni, S., & Kondapavuluru, P. V. (2002). Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. Journal of Affective Disorders, 70(1), 19–26.CrossRefGoogle ScholarPubMed
Reis, M., & Kallen, B. (2008). Maternal use of antipsychotics in early pregnancy and delivery outcome. Journal of Clinical Psychopharmacology, 28(3), 279–288.CrossRefGoogle ScholarPubMed
Sadowski, A., Todorow, M., Yazdani Brojeni, P., Koren, G., & Nulman, I. (2013). Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: A cohort study. BMJ Open, 3(7), e003062. https://bmjopen.bmj.com/content/3/7/e003062.full.CrossRefGoogle ScholarPubMed
Scholl, T. O., Sowers, M., Chen, X., & Lenders, C. (2001). Maternal glucose concentration influences fetal growth, gestation, and pregnancy complications. American Journal of Epidemiology, 154(6), 514–520.CrossRefGoogle ScholarPubMed
Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605.CrossRefGoogle ScholarPubMed
Toh, S., Li, Q., Cheetham, T. C., Cooper, W. O., Davis, R. L., Dublin, S., … Pinheiro, S. P. (2013). Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: A population-based study of 585615 deliveries. Archives of Women's Mental Health, 16(2), 149–157.CrossRefGoogle Scholar
Uguz, F. (2019). Antipsychotic use during pregnancy and the risk of gestational diabetes mellitus: A systematic review. Journal of Clinical Psychopharmacology, 39(2), 162–167.CrossRefGoogle ScholarPubMed
Valenstein, M., Blow, F. C., Copeland, L. A., McCarthy, J. F., Zeber, J. E., Gillon, L., … Stavenger, T. (2004). Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors. The Journal of Psychoses and Related Disorders 30(2), 255–264.Google ScholarPubMed
Vesco, K. K., Dietz, P. M., Bulkley, J., Bruce, F. C., Callaghan, W. M., England, L., … Hornbrook, M. C. (2012). A system-based intervention to improve postpartum diabetes screening among women with gestational diabetes. American Journal of Obstetrics & Gynecology, 207(4), 283. e281–283. e286.CrossRefGoogle ScholarPubMed
Vesga-Lopez, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. (2008). Psychiatric disorders in pregnant and postpartum women in the United States. Archives of General Psychiatry, 65(7), 805–815.CrossRefGoogle ScholarPubMed
Vigod, S. N., Gomes, T., Wilton, A. S., Taylor, V. H., & Ray, J. G. (2015). Antipsychotic drug use in pregnancy: High dimensional, propensity matched, population based cohort study. BMJ (Online), 350(no pagination), h2298.CrossRefGoogle ScholarPubMed
Wang, Z., Ho, P. W. H., Choy, M. T. H., Wong, I. C. K., Brauer, R., & Man, K. K. C. (2018). Advances in epidemiological methods and utilisation of large databases: A methodological review of observational studies on central nervous system drug use in pregnancy and central nervous system outcomes in children. Drug Safety, 42(4), 499–513.CrossRefGoogle Scholar
Yonkers, K. A., Vigod, S., & Ross, L. E. (2012). Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. The Journal of Lifelong Learning in Psychiatry, 10(1), 51–66.CrossRefGoogle Scholar
Yood, M. U., DeLorenze, G. N., Quesenberry, C. P., Oliveria, S. A., Tsai, A.-L., Kim, E., … L'italien, G. J. (2011). Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: Does the effect differ by dose? BMC Psychiatry, 11(1), 197.CrossRefGoogle Scholar
Supplementary material: File

Wang et al. supplementary material

Wang et al. supplementary material 1

Download Wang et al. supplementary material(File)
File 28.8 KB
Supplementary material: File

Wang et al. supplementary material

Wang et al. supplementary material 2

Download Wang et al. supplementary material(File)
File 27.7 KB